UNSPSC 85812411: Introduction of anti-inflammatory into mouth and pharynx, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of anti-inflammatory into mouth and pharynx, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0D73Z

UNSPSC 85812411 Introduction of anti-inflammatory into mouth and pharynx via natural or artificial opening (Commodity) shows minimal recent state and local procurement activity directly aligned with the code's nominal scope. The four recent opportunities posted under this code span virtual urgent care services, general medical services, nursing home operations, and rural healthcare network facilitation—none of which involve administration of anti-inflammatory medications to the mouth or pharynx as a discrete clinical service line. State and local governments buying under this code appear to be telehealth providers, health authorities, and behavioral health agencies rather than outpatient clinics or surgical centers specializing in oral or pharyngeal treatment.

The issuing bodies include California's Inland Empire Health Plan (health plan), Nevada Health Authority (state agency), and DeKalb County, Georgia (county government), reflecting a mix of regional health plans and state-level purchasing. Geographic activity centers on California and Nevada, with one Georgia opportunity. Representative recent solicitations include the Inland Empire Health Plan's RFI for Virtual Urgent Care Services (posted October 16, 2026, with responses due October 31, 2026) seeking telehealth evaluation and medication prescribing authority, and the Nevada Health Authority's RFP for Program of All Inclusive Care for the Elderly operations (posted October 8, 2026, proposals due December 10, 2026), which bundles comprehensive senior services including pharmacy and medical management but does not isolate anti-inflammatory administration to the oral cavity as a standalone contract line. The code appears to be a mislabeled or overly broad classification for the actual work being solicited, warranting verification against the underlying procurement scope before pursuing opportunities tagged with this code.